Cargando…
Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance
Fc domain fusion can improve the therapeutic effects of relatively small biological molecules such as peptides, cytokines, and antibody fragments. Fc fusion proteins can also be used to enhance the cytotoxic effects of small bispecific antibodies (bsAbs). However, fragmentation of Fc fusion proteins...
Autores principales: | Suzuki, Saori, Annaka, Hiroaki, Konno, Shota, Kumagai, Izumi, Asano, Ryutaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250740/ https://www.ncbi.nlm.nih.gov/pubmed/30467410 http://dx.doi.org/10.1038/s41598-018-35489-y |
Ejemplares similares
-
Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction
por: Yamada, Risa, et al.
Publicado: (2023) -
Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae
por: Jørgensen, Mathias Lindh, et al.
Publicado: (2014) -
Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
por: Asano, Ryutaro, et al.
Publicado: (2014) -
Engineered IgG1‐Fc – one fragment to bind them all
por: Lobner, Elisabeth, et al.
Publicado: (2016) -
Engineering IgG-Like Bispecific Antibodies—An Overview
por: Krah, Simon, et al.
Publicado: (2018)